Evolutionary Genomics, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 15 rows, 15 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2022-05-23: Reporting owner Messier Walter; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2022-05-23: Reporting owner WARNECKE STEVE B; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2022-05-23: Reporting owner Orndorff Virginia P.; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2022-03-25: Reporting owner WARNECKE STEVE B; Form 4; Security Stock Options (right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2022-05-23 | Messier Walter Officer (Secretary / Treasurer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −100,000 0 owned after | $0.55 exercise price | 2022-05-25 | |
| 2022-05-23 | WARNECKE STEVE B Director, Officer (Chairman, CEO), 10% Owner | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −66,667 0 owned after | $0.55 exercise price | 2022-05-25 | |
| 2022-05-23 | Orndorff Virginia P. Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −20,000 0 owned after | $0.55 exercise price | 2022-05-25 | |
| 2022-03-25 | WARNECKE STEVE B Director, Officer (Chairman/CEO), 10% Owner | 4 | Stock Options (right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +133,333 133,333 owned after | $0.83 exercise price | 2022-03-31 | |
| 2019-10-28 | Boggess Mark Virgil Director | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +45,000 45,000 owned after | $1.50 exercise price | 2019-10-29 | |
| 2019-10-28 | WARNECKE STEVE B Director, Officer (Chairman/CEO), 10% Owner | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +150,000 150,000 owned after | $1.65 exercise price | 2019-10-29 | |
| 2019-10-28 | Orndorff Virginia P. Director | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +45,000 45,000 owned after | $1.50 exercise price | 2019-10-29 | |
| 2016-02-19 | Boggess Mark Virgil Director | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $3.00 exercise price | 2019-10-29 | |
| 2016-02-19 | WARNECKE STEVE B Director, Officer (Chairman/CEO), 10% Owner | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $3.30 exercise price | 2019-10-29 | |
| 2016-02-19 | Orndorff Virginia P. Director | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $3.00 exercise price | 2019-10-29 | |
| 2015-10-21 holding as of filing | Orndorff Virginia P. Director | 3 | Options Derivative · Direct | Holding | $0.55 exercise price | 2015-10-21 | ||
| 2014-10-01 | WARNECKE STEVE B Director, Officer (CFO/Secretary/Treasurer), 10% Owner | 4 | Call Option Derivative · Indirect · See footnote | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,252,233 0 owned after | $0.01 | 2014-10-03 | |
| 2014-10-01 | WARNECKE STEVE B Director, Officer (CFO/Secretary/Treasurer), 10% Owner | 4 | Call Option Derivative · Indirect · See footnote | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,222,950 0 owned after | $0.00 | 2014-10-03 | |
| 2014-06-16 holding as of filing | WARNECKE STEVE B Director, Officer (Chief Financial Officer, TSD) | 3 | Call Option (right to buy) Derivative · Indirect · See Footnote | Holding | $0.01 exercise price | 2014-06-16 | ||
| 2014-06-16 holding as of filing | WARNECKE STEVE B Director, Officer (Chief Financial Officer, TSD) | 3 | Call Option (right to buy) Derivative · Indirect · See Footnote | Holding | no price filed | 2014-06-16 |